Recombinant Human LCN1/Lipocalin-1 Protein，His

LCN1, also known as Lipocalin-1, is a member of the lipocalin family of proteins that play a pivotal role in various biological processes, including immune response, inflammation, and tissue remodeling. Initially discovered in the context of mammalian development, LCN1 has garnered significant attention due to its involvement in cancer progression, particularly in relation to tumor growth and metastasis. Elevated levels of LCN1 have been correlated with poor prognosis in various cancers, leading to investigations into its functional mechanisms and potential as a therapeutic target. The recombinant expression of LCN1 has become a focal point of research, as it allows for the detailed study of its structure-function relationships, as well as its interactions with other biomolecules. This research is essential for understanding how LCN1 influences tumor microenvironments and systemic pathways. The production of recombinant LCN1 not only facilitates biochemical assays but also opens avenues for developing novel diagnostic and therapeutic strategies aimed at modulating LCN1 activity. Furthermore, studying the post-translational modifications and regulatory mechanisms governing LCN1 expression can provide deeper insights into its role in health and disease, potentially leading to improved treatment options for cancer patients.